Document Detail


Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.
MedLine Citation:
PMID:  10762559     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Prolonged administration of nucleoside analogues for chronic hepatitis B may result in the emergence of hepatitis B viral polymerase mutants. To gain insight into the mechanism involved in the virus's resistance to famciclovir, the amino acid sequences of the terminal protein and reverse-transcriptase (RT) domains of the viral polymerase were determined during therapy among 28 patients. The antiviral response was independent of viral genotypes, and nonresponse to famciclovir was associated with a complex variability of the RT domain. No mutation in the YMDD motif was observed, whereas an L528M mutation was clearly selected by famciclovir treatment in 2 patients, as well as 14 novel mutations in 7 patients. Clone sequence analysis of the RT domains of patients undergoing retreatment with famciclovir and/or lamivudine showed the selection of a preexisting drug-resistant mutant in one case and indicated that sequential antiviral therapy may allow the rapid selection of resistant strains.
Authors:
B Seignères; C Pichoud; S S Ahmed; O Hantz; C Trépo; F Zoulim
Related Documents :
17711379 - Utility of repeat genotypic resistance testing and clinical response in patients with t...
19026009 - Naturally occurring dominant resistance mutations to hepatitis c virus protease and pol...
17086059 - Routine surveillance for the detection of acute and recent hiv infections and transmiss...
15951729 - New drugs for old.
9284369 - Recombination in hiv: an important viral evolutionary strategy.
20580309 - Acute hepatitis b infection associated with drug-resistant hepatitis b virus.
22521559 - Hepatitis c infection in childhood.
18925639 - Histological changes in hcv antibody-positive, hcv rna-negative subjects suggest persis...
10815739 - Hiv-1 co-infection in children hospitalised with tuberculosis in south africa.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't     Date:  2000-04-13
Journal Detail:
Title:  The Journal of infectious diseases     Volume:  181     ISSN:  0022-1899     ISO Abbreviation:  J. Infect. Dis.     Publication Date:  2000 Apr 
Date Detail:
Created Date:  2000-06-01     Completed Date:  2000-06-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0413675     Medline TA:  J Infect Dis     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1221-33     Citation Subset:  AIM; IM    
Affiliation:
Institut National de la Santé et de la Recherche Médicale (INSERM) Unit 271, Lyon, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
2-Aminopurine / analogs & derivatives*,  therapeutic use
Adult
Amino Acid Sequence
Antiviral Agents / therapeutic use*
Cloning, Molecular
Drug Resistance, Microbial / genetics
Evolution, Molecular*
Female
Gene Products, pol / chemistry,  genetics*
Hepatitis B e Antigens / analysis
Hepatitis B virus / enzymology*
Hepatitis B, Chronic / drug therapy,  enzymology*,  genetics
Humans
Longitudinal Studies
Male
Middle Aged
Molecular Sequence Data
RNA-Directed DNA Polymerase / chemistry,  genetics*
Sequence Alignment
Chemical
Reg. No./Substance:
0/Antiviral Agents; 0/Gene Products, pol; 0/Hepatitis B e Antigens; 0/P protein, Hepatitis B virus; 104227-87-4/famciclovir; 452-06-2/2-Aminopurine; EC 2.7.7.49/RNA-Directed DNA Polymerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Genomewide search and genetic localization of a second gene associated with autosomal dominant branc...
Next Document:  Use of herpes simplex virus (HSV) type 1 ISCOMS 703 vaccine for prophylactic and therapeutic treatme...